Gulf Pharmaceutical Industries P.S.C. (JULPHAR.AD)

Also known as:  Julphar
Data delayed by 15 minutes
1.02 AED -0.03-2.86%
As of 07 JUL 2020 10:00 GMT|Abu Dhabi SE

Julphar Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
0.0
Upside
-
Target Price (Mean)
-
52Wk
0.539 29 APR
1.535 07 JUN

Open
1.05 AED
Previous Close
1.05 AED
Turnover
834.02K AED
EPS
-
Volume
805,650
Transactions
10
Market Cap
1.21B AED
IPO Date
20-Oct-2002
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Gulf Pharmaceutical Industries P.S.C.Last updated on: 29 June 2020

Business Summary
Manufacture of generic drugs, medical supplies, vitamins, cosmetics and skin care products.
Country of Incorporation
Ownership Type
Established In
1980
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
JULPHAR.ADOrdinaryAEDAbu Dhabi SEJULPHAR

Contact details

Primary address
Julphar Complex
Airport Road
Digdaga Area
997
UAE
Ras Al Khaimah
CONTACT
  • Tel: +971 7-246-1461
  • Tel: +971 7-204-5273
  • Fax: +971 7-246-2462
  • Fax: +971 7-246-1462
  • Email: www.julphar.net
Region
Ras Al Khaimah
More

Julphar resumes sales of products in Bahrain and Kuwait

After an inspection of Julphar facilities, the Gulf Health Council and the Pharmaceutical & Herbal Medicine Registration & Quality Control Admin, Ministry of Health, State of Kuwait has lifted the temporary suspension on the export of Julphar products to Bahrain and Kuwait

Press Release - 09 Jun 2020

Julphar resumes sales of products in KSA

After an inspection of Julphar facilities, Saudi Food and Drug Authority has lifted the temporary suspension on the export of Julphar products to Saudi Arabia

Press Release - 30 Apr 2020
All Press Releases
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Essam Farouk Hussein Mohammed
Chief Executive Officer
Mr Juergen Wolfgang Lauterbach
Chief Financial Officer and Chief Strategy Officer
Mr Georges Ibrahim
Chief Quality Officer

Board Members

HH Sheikh Sakr Bin Humaid Bin Abdullah Al Qassimi
Chairman
Mr Yousef Ali Mohammed Ghuloom Al Blooshi
Vice Chairman
Dr Ali Hussein Ali Al Zawawi
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
AMANAT HOLD0.904 AED0.44
GULF MEDICAL2.620 AED14.912
More

Tuesday Outlook: Asian shares step back; dollar wallows

Tuesday Outlook: Asian shares step back; dollar wallows

Oil prices inch higher; Gold firms over virus concerns 

More

Most Viewed Stocks

Stock Screener

More